Clopitab-A 75 Capsule belongs to the class of antiplatelet drugs used for the prevention of heart attack and stroke. A heart attack occurs when a blood clot blocks the blood flow to the heart. This blockage of arteries is most often an accumulation of fat, cholesterol and other substances, which form a plaque in the arteries that feed the heart (coronary arteries). Signs of a heart attack include chest pain, upper body pain, sweating, nausea, fatigue and trouble breathing.

Clopitab-A 75 Capsule is composed of two medicines, namely: Aspirin and Clopidogrel. These are blood thinners (anti-platelet) that prevent the formation of a clot in the blood vessels. Aspirin acts as a blood-thinning or anti-platelet agent in a low dose (about 75 mg) to prevent heart attack and stroke. Clopidogrel acts by preventing blood clots if you have severe chest pain (unstable angina or heart attack), stroke, and peripheral arterial disease (heart problem due to narrowed blood vessels). Clopitab-A 75 Capsule helps in the free flow of blood, thereby preventing a heart attack, stroke, deep vein thrombosis (blood clot in the vein), and pulmonary embolism (blood clots in the arteries of lungs).

Your doctor will advise you on how often you take your tablets based on your medical condition. The common side effects of Clopitab-A 75 Capsule include abdominal pain, indigestion, diarrhoea, easy bruising, and nosebleeds. Clopitab-A 75 Capsule is known to cause dizziness and blurry vision, so driving should be avoided. Most of these side effects of Clopitab-A 75 Capsule do not require medical attention and gradually resolve over time. However, if the side effects are persistent, reach out to your doctor.

Try not to stop taking this medicine of your own. Stopping Clopitab-A 75 Capsule may worsen your condition and increase the risk of a future heart attack. Let your doctor know if are sensitive to clopidogrel or aspirin, have kidney/liver diseases, bleeding issues (like peptic ulcer, brain haemorrhage), pregnant or planning to become pregnant or breastfeeding. The patient should inform the doctor that they are taking Clopitab-A 75 Capsule before any surgery is scheduled or any new medicine is taken. 

Clopitab-A 75 Capsule is composed of Aspirin and Clopidogrel, which act as blood thinners (anti-platelet) and prevent the formation of a clot in the blood vessels. Aspirin acts as a blood-thinning or anti-platelet agent in a low dose (about 75 mg) to prevent heart attack and stroke. Clopidogrel acts by preventing blood clots if you have severe chest pain (unstable angina or heart attack), stroke, and peripheral arterial disease (heart problem due to narrowed blood vessels). Clopitab-A 75 Capsule helps in the free flow of blood, thereby preventing heart attack, stroke, deep vein thrombosis (blood clot in the vein), and pulmonary embolism (blood clots in the arteries of lungs).

You should avoid taking Clopitab-A 75 Capsule if you are allergic to Clopitab-A 75 Capsule . Let your doctor know if you have a medical condition that is causing bleeding such as a haemophilia, stomach ulcer or bleeding within your head or bowel. Caution is required before giving Clopitab-A 75 Capsule to the liver or kidney problems patients. People affected with respiratory problems like asthma, rhinitis or nasal polyps should consult a doctor before intake of Clopitab-A 75 Capsule . Clopitab-A 75 Capsule is not recommended for the breastfeeding mother as it passes into the breast milk. The safety and effectiveness of Clopitab-A 75 Capsule in children less than 12 years of age have not been established. 

Let your doctor know that you are using Clopitab-A 75 Capsule if you have a scheduled surgery since this medicine may increase the risk of bleeding.